Cart
sales@molnova.com
Home - Products - Cell Cycle/DNA Damage - c-Myc - KJ-Pyr-9

KJ-Pyr-9

CAS No. 581073-80-5

KJ-Pyr-9( KJ Pyr9 )

Catalog No. M15131 CAS No. 581073-80-5

KJ-Pyr-9 is a novel small-molecule inhibitor of c-Myc (Kd=6.5 ± 1.0 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 54 In Stock
2MG 31 In Stock
5MG 49 In Stock
10MG 70 In Stock
25MG 141 In Stock
50MG 272 In Stock
100MG 498 In Stock
200MG 669 In Stock
500MG 1042 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    KJ-Pyr-9
  • Note
    Research use only, not for human use.
  • Brief Description
    KJ-Pyr-9 is a novel small-molecule inhibitor of c-Myc (Kd=6.5 ± 1.0 nM).
  • Description
    KJ-Pyr-9 is a novel small-molecule inhibitor of c-Myc (Kd=6.5 ± 1.0 nM); interferes with MYC-MAX complex formation and inhibits MYC-induced oncogenic transformation in cells; active in xenograft mice.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    KJ Pyr9
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    c-Myc
  • Recptor
    c-Myc
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    581073-80-5
  • Formula Weight
    385.3722
  • Molecular Formula
    C22H15N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(N)C1=CC=C(C2=CC(C3=CC=CO3)=NC(C4=CC=C([N+]([O-])=O)C=C4)=C2)C=C1
  • Chemical Name
    Benzamide, 4-[2-(2-furanyl)-6-(4-nitrophenyl)-4-pyridinyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hart JR, et al. Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12556-61. 2. Raffeiner P, et al. Oncotarget. 2014 Oct 15;5(19):8869-78.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • MYCi361

    MYCi361 is an inhibitor of MYC (binding to MYC with Kd of 3.2 μM). MYCi361 is a small-molecule MYC inhibitors that inhibits the viability of MYC-dependent cancer cells including prostate cancer (MycCaP, LNCaP, and PC3), leukemia (MV4-11), lymphoma (HL-60 and P493-6), and neuroblastoma (SK-N-B2) with low-micromolar IC50 values.

  • Magnoflorine

    Sinomeni Caulis et Rhizoma has sedative and anxiolytic effects, probably mediated by Magnoflorine through a GABAergic mechanism of action.

  • APTO-253

    APTO-253 inhibits c-Myc expression, stabilizes G-quadruplex DNA, and induces cell cycle arrest and apoptosis in acute myeloid leukemia cells. APTO-253 mediates anticancer activity through the induction of the KLF4 tumor suppressor.APTO-253 (5 μM) induces KLF4 expression and enhances apoptosis induced by NSC 119875 in both SKOV3 and OVCAR3 cells.

Sign In Join Free